GENE ONLINE|News &
Opinion
Blog

Deals
BBL to Take Over Biosimilars Business from Viatris 
2022-03-02
BIO CEO 2022: Trends and Opportunities in Biotechnology Investments
2022-02-26
tRNA Startup Clinches $24 Million from ARCH, Takeda and 8VC to Fix Protein Mutations
2022-02-25
Plexium Bags $102 Million for Targeted Protein Degraders
2022-02-24
Pfizer, Lilly-Backed Neuro Company Bags $64 Million Series B To Correct Progranulin Deficiency in Dementia
2022-02-11
EdiGene Digs Into Cell Therapies with Arbor and Neukio Partnerships
2022-02-10
Pfizer and Alex Therapeutics Ink Partnership for Providing Digital Therapeutics to Patients, Starting in Germany
2022-02-04
MindMed’s MM-120 May Give a New Hope for Generalized Anxiety Disorder
2022-01-30
Fujifilm Expands CDMO Operations by Buying Atara’s Cell Therapy Plant for $100 Million
2022-01-27
Google-Backed Leyden Labs Closes $140 Million Series B to Fight Viruses with Nasal Spray
2022-01-26
OpenBiome and the University of Minnesota collaborate to give Microbes to those in Need
2022-01-26
Psychedelics Player Goes Public via SPAC
2022-01-25
South Korea’s SK Inc., Develops Its CDMO Capabilities via Investment in the Center for Breakthrough Medicines
2022-01-21
UCB Strengthens Its Rare Disease Portfolio with Its Newest Acquisition
2022-01-20
APAC CRO Novotech Mulls IPO after $255 Million Round
2022-01-20
1 22 23 24 25 26 47
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top